Effects of glucagon on free fatty acid metabolism in humans.

To determine whether physiological changes in plasma glucagon concentrations are important in regulating basal adipose tissue lipolysis, FFA flux ([1-14C]palmitate) was measured in response to increases and decreases in plasma glucagon. Eight volunteers with insulin-dependent diabetes mellitus (IDDM) and nine healthy nondiabetic volunteers were studied using the pancreatic clamp technique to control plasma insulin, GH, and glucagon concentrations at desired levels. Palmitate flux at the chosen euglucagonemic hormone infusion rates was similar to baseline values (1.73 +/- 0.12 vs. 1.75 +/- 0.23 and 1.35 +/- 0.18 vs. 1.35 +/- 0.16 mumol/kg.min, respectively, in IDDM and nondiabetic subjects). No significant changes in palmitate flux occurred in response to glucagon withdrawal or mild (nondiabetic volunteers) or high physiological (IDDM volunteers) hyperglucagonemia. Thus, under conditions of normal FFA availability, changes in plasma glucagon concentrations within the physiological range have little or no effect on adipose tissue lipolysis.

[1]  S. Coppack,et al.  Lack of effect of hyperglycemia on lipolysis in humans. , 1990, The American journal of physiology.

[2]  G. Reaven,et al.  Does glucagon increase plasma free fatty acid concentration in humans with normal glucose tolerance? , 1990, The Journal of clinical endocrinology and metabolism.

[3]  M. Jensen,et al.  Insulin Regulation of Lipolysis in Nondiabetic and IDDM Subjects , 1989, Diabetes.

[4]  M. Jensen,et al.  Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. , 1988, The American journal of physiology.

[5]  G. Shulman,et al.  Hormonal control of substrate cycling in humans. , 1988, The Journal of clinical investigation.

[6]  K. Nair,et al.  Hyperglucagonemia during insulin deficiency accelerates protein catabolism. , 1987, The American journal of physiology.

[7]  M. Jensen,et al.  Validation of a new method for determination of free fatty acid turnover. , 1987, The American journal of physiology.

[8]  G. Bolli,et al.  Treatment of Diabetes with L363,586 , 1987 .

[9]  M. Jensen,et al.  Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. , 1987, The Journal of clinical investigation.

[10]  H. Mehnert,et al.  Evidence for a Substrate Regulation of Triglyceride Lipolysis in Human Skeletal Muscle , 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  M. Taskinen,et al.  Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. , 1984, The Journal of clinical endocrinology and metabolism.

[12]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[13]  K. Chatzipanteli,et al.  Streptozotocin diabetes results in increased responsiveness of adipocyte lipolysis to glucagon , 1983, FEBS letters.

[14]  G. Sonnenberg,et al.  Role of Glucagon in Enhancing Ketone Body Production in Ketotic Diabetic Man , 1983, Diabetes.

[15]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.

[16]  N. Abumrad,et al.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. , 1981, Metabolism: clinical and experimental.

[17]  P. Cryer,et al.  Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [l-13C]palmitic acid. , 1981, The Journal of clinical investigation.

[18]  P. Nestel,et al.  Diminished plasma free fatty acid clearance in obese subjects. , 1978, Metabolism: clinical and experimental.

[19]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[20]  E. Tsalikian,et al.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. , 1976, The Journal of clinical investigation.

[21]  Eaton Rp,et al.  Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects. , 1975 .

[22]  B. Jaffe,et al.  Methods of Hormone Radioimmunoassay , 1974 .

[23]  S. B. Lewis,et al.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. , 1974, The Journal of clinical investigation.

[24]  J. Gerich,et al.  Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect , 1973, Science.

[25]  R. G. Wieland,et al.  Growth hormone response to intramuscular glucagon. , 1973, The Journal of clinical endocrinology and metabolism.

[26]  K. Mashimo,et al.  A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients , 1973, Diabetes.

[27]  G. Pozza,et al.  Lipolytic effect of intra-arterial injection of glucagon in man. , 1971, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[28]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[29]  T. Burns,et al.  Observations on lipolysis with isolated adipose tissue cells. , 1968, The Journal of laboratory and clinical medicine.

[30]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[31]  R. Havel,et al.  Turnover rate and oxidation of free fatty acids of blood plasma in man during exercise: studies during continuous infusion of palmitate-1-C14. , 1963, The Journal of clinical investigation.

[32]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[33]  E. Knoblock,et al.  Elevation of plasma epinephrine levels produced by glucagon in vivo. , 1963, Endocrinology.

[34]  J. H. Hagen.  Effect of glucagon on the metabolism of adipose tissue. , 1961, The Journal of biological chemistry.